Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators. Shows potential in the development of central nervous system agents, particularly for treating anxiety, depression, and neurodegenerative disorders. Its structure supports high affinity binding to 5-HT1A receptors, making it valuable in creating selective pharmacological agents. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved metabolic stability and blood-brain barrier penetration.